Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vascular Biogenics Ltd. (VBLT)

1.23   -0.05 (-3.91%) 07-01 16:00
Open: 1.27 Pre. Close: 1.28
High: 1.27 Low: 1.22
Volume: 142,040 Market Cap: 59M
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer. The company's program is based on its proprietary vascular targeting system platform technology, which utilizes genetically targeted therapy to destroy newly formed or angiogenic blood vessels. Its lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; and in Phase III clinical trials for recurrent platinum-resistant ovarian cancer, as well as for Phase II clinical trials for iodine-resistant differentiated thyroid cancer. The company is also developing VB-111, which is in Phase I clinical trials for the treatment of patients with various types of advanced metastatic cancer types, including thyroid cancer, neuroendocrine cancer, renal cell carcinoma, and lung cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.272 - 1.279 1.279 - 1.285
Low: 1.201 - 1.211 1.211 - 1.218
Close: 1.217 - 1.231 1.231 - 1.242

Technical analysis

as of: 2020-07-01 4:37:59 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.66     One year: 1.89
Support: Support1: 1.09    Support2: 0.91
Resistance: Resistance1: 1.42    Resistance2: 1.62
Pivot: 1.27
Moving Average: MA(5): 1.27     MA(20): 1.28
MA(100): 1.29     MA(250): 1.28
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 32.70     %D(3): 33.88
RSI: RSI(14): 46.03
52-week: High: 1.64  Low: 0.90  Change(%): -5.4
Average Vol(K): 3-Month: 61143  10-Days: 46680

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
VBLT has closed above bottom band by 28.2%. Bollinger Bands are 47.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to VBLT's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 30 Jun 2020
Vascular Biogenics Ltd. (VBLT) Might Be Poised For A Short Term Move - Invest Million

Thu, 25 Jun 2020
Growth Investors: Industry Analysts Just Upgraded Their Vascular Biogenics Ltd. (NASDAQ:VBLT) Revenue Forecasts By 24% - Yahoo Finance

Tue, 23 Jun 2020
Vascular Biogenics Ltd. (NASDAQ:VBLT) 28.57% Above its 52-week Low, How Long Will it Keep Rising? - Marketing Sentinel

Thu, 18 Jun 2020
Vascular Biogenics Ltd. (VBLT): What is good about stock? - Marketing Sentinel

Thu, 18 Jun 2020
How Does Vascular Biogenics Ltd (VBLT) Stock Rank in the Healthcare Sector? - InvestorsObserver

Wed, 17 Jun 2020
Market's View on Vascular Biogenics Ltd (VBLT) Stock's Price & Volume Trends - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48
Shares Float (M) 20
% Held by Insiders 26.73
% Held by Institutions 22.85
Shares Short (K) 252
Shares Short P. Month (K) 76

Stock Financials

EPS -0.574
EPS Est This Year -0.740
EPS Est Next Year -0.780
Book Value (p.s.) 0.860
Profit Margin
Operating Margin -2995.35
Return on Assets (ttm) -25.7
Return on Equity (ttm) -50.9
Qtrly Rev. Growth 67.1
Gross Profit (p.s.) 0.008
Sales Per Share 0.015
EBITDA (p.s.) -0.422
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -8

Stock Valuations

PE Ratio -2.14
PEG Ratio
Price to Book value 1.43
Price to Sales 83.10
Price to Cash Flow -3.78

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.